Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares)
-
Shares outstanding
-
239,647,920
-
Total 13F shares
-
36,381,057
-
Share change
-
+2,723,970
-
Total reported value
-
$9,932,901,818
-
Put/Call ratio
-
162%
-
Price per share
-
$272.99
-
Number of holders
-
326
-
Value change
-
+$800,351,672
-
Number of buys
-
173
-
Number of sells
-
127
Institutional Holders of BioNTech SE - Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares) (BNTX) as of Q3 2021
As of 30 Sep 2021,
BioNTech SE - Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares) (BNTX) was held by
326 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
36,381,057 shares.
The largest 10 holders included
BAILLIE GIFFORD & CO, PRIMECAP MANAGEMENT CO/CA/, JENNISON ASSOCIATES LLC, Capital World Investors, FMR LLC, Fosun International Ltd, BlackRock Inc., Pendal Group Ltd, PRICE T ROWE ASSOCIATES INC /MD/, and COATUE MANAGEMENT LLC.
This page lists
330
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.